Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About William Sheridan

The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $2,658,421 for William Sheridan in fiscal 2022, including a base salary of $549,171. Disclosed compensation is on record for 6 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Biocryst Pharmaceuticals Inc

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Biocryst Pharmaceuticals Inc (BCRX) $549,171 $2,658,421
2021 Biocryst Pharmaceuticals Inc (BCRX) $530,600 $2,531,231
2020 Biocryst Pharmaceuticals Inc (BCRX) $515,146 $2,679,920
2019 Biocryst Pharmaceuticals Inc (BCRX) $500,142 $1,067,183
2018 Biocryst Pharmaceuticals Inc (BCRX) $485,574 $2,349,219
2017 Biocryst Pharmaceuticals Inc (BCRX) $469,143 $1,808,550

Recent activity

No call appearances or filed executive changes recorded yet.